Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Aug 15, 2025, 3:59 PM
2.12
0.47%
After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
276K 12.35M 21.44M 35.34M 8.31M 41.27M 2.79M 9.32M
Cost of Revenue
-29.08M 29.08M 24.57M 15.73M 13.35M 12.48M 12.9M 10.6M
Gross Profit
29.35M -16.73M -3.13M 19.62M -5.04M 28.79M -10.11M -1.28M
Operating Income
-25.26M -26.31M -12.27M -5.25M -28.8M 4.17M -30.9M -26.58M
Interest Income
101K 2.54M 11.94M 965K 348K 2K 2K 5.5K
Pretax Income
-24.71M -24.76M -9.29M -3.14M -68.11M 2.11M -29.42M -28.65M
Net Income
-24.71M -24.76M -9.29M 1.72M -64.41M 6.3M -29.09M -23.72M
Selling & General & Admin
2.35M 9.58M 9.14M 8.54M 9.57M 11.37M 5.51M 13.38M
Research & Development
22.9M 29.08M 24.57M 28.41M 25.16M 23.68M 25.81M 20.32M
Other Expenses
29.36M -29.08M n/a n/a n/a n/a n/a n/a
Operating Expenses
54.61M 9.58M 8.06M 36.95M 34.73M 35.05M 31.32M 33.71M
Interest Expense
34K 600K 3.02M 324K 94K n/a n/a n/a
Selling & Marketing Expenses
-164K 164K 174K 71K 77.5K 187.5K 139K 57.5K
Cost & Expenses
25.54M 38.66M 32.63M 40.6M 37.11M 37.1M 33.69M 35.9M
Income Tax Expense
n/a n/a -9.75M -4.85M -3.77M -4.27M -7.66M -4.93M
Shares Outstanding (Basic)
81.05M 79.88M 80.59M 80.32M 80.19M 79.74M 79.54M 79M
Shares Outstanding (Diluted)
81.05M 80.87M 80.59M 83.78M 80.19M 81.87M 79.54M 79M
EPS (Basic)
-0.3 -0.31 -0.12 0.02 -0.8 0.08 -0.37 -0.3
EPS (Diluted)
-0.3 -0.31 -0.12 0.02 -0.8 0.08 -0.37 -0.3
EBITDA
-21.35M -25.56M -10.4M 832K -65.64M 6.22M -26.91M -24.39M
EBIT
-22.59M -26.31M -12.27M -2.81M -12.46M 4.25M -29.28M -28.47M
Depreciation & Amortization
1.24M 750K 1.87M 3.65M 2.38M 2.04M 2.38M 2.19M